JUNS
Jupiter Neurosciences, Inc. Common StockNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$12.70M
P/E Ratio
—
EPS
$-0.25
Beta
—
52W High
$3.33
52W Low
$0.31
50-Day MA
$0.50
200-Day MA
$1.15
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
6.97
PEG Ratio
—
About Jupiter Neurosciences, Inc. Common Stock
Jupiter Neurosciences, Inc., a clinical stage research and development pharmaceutical company, develops resveratrol platform products primarily for the treatment of neuroinflammation. The company is headquartered in Jupiter, Florida.
Fundamentals
| Revenue (TTM) | 21,800 |
| Gross Profit (TTM) | $-2.07M |
| EBITDA | — |
| Operating Margin | -12887.00% |
| Return on Equity | -739.00% |
| Return on Assets | -94.60% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.00 |
| Price-to-Book | 227.66 |
| Price-to-Sales (TTM) | 582.60 |
| EV/Revenue | 652.55 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $36.28M |
| Float | $17.36M |
| % Insiders | 51.34% |
| % Institutions | 4.43% |
Data last updated: 4/8/2026